Large gap with delayed quotes
|
Last quote
07/01/2025
-
16:44:47
|
Bid
07/01/2025 -
16:45:10
|
Bid Volume |
Ask
07/01/2025 -
16:45:10
|
Ask Volume |
|---|---|---|---|---|
|
130.82
+5.23
(
+4.16% )
|
130.55
|
200 |
130.87
|
100 |
Analysis date: 27.06.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 20.06.2025.
Interest
Weak
Weak
Two stars since 20.06.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 20.06.2025 at a price of 127.04.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 20.05.2025.
4wk Rel Perf
-6.05%
-6.05%
The four-week dividend-adjusted underperformance versus SP500 is 6.05%.
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.20%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.90%.
Mkt Cap in $bn
18.47
18.47
With a market capitalization >$8bn, BIOGEN is considered a large-cap stock.
G/PE Ratio
0.58
0.58
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
7.90
7.90
The estimated PE is for the year 2027.
LT Growth
4.59%
4.59%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
28
28
Over the last seven weeks, an average of 28 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
43
43
For 1% of index variation, the stock varies on average by 0.43%.
Correlation
0.36
0.36
Stock movements are strongly independent of index variations.
Value at Risk
15.14
15.14
The value at risk is estimated at USD 15.14. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002